Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Acta Naturae ; 5(3): 74-8, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24303202

RESUMO

We studied the cytotoxicity of acadesine (5-aminoimidazole-4-carboxamide-1-ß-D-ribofuranoside) for tumor and normal cells of various species and tissue origin. In tumor cells, acadesine triggered non-apoptotic death; the potency of the compound to normal cells was substantially lower. Acadesine was toxic for tumor cells with multidrug resistant phenotypes caused by the transmembrane transporter Р-glycoprotein or lack of proapoptotic p53. Activity of adenosine receptors was required for acadesine-induced cell death, whereas functioning of АМР-dependent protein kinase was not required. A more pronounced cytotoxicity for tumor cells, as well as the non-canonical death mechanism(s), makes acadesine a promising candidate for antitumor therapy.

2.
Bull Exp Biol Med ; 153(6): 878-81, 2012 Oct.
Artigo em Inglês, Russo | MEDLINE | ID: mdl-23113308

RESUMO

We studied the expression of peroxiredoxin genes (PRDX1, PRDX2, PRDX3, and PRDX6) in human erythroleukemia K652, human breast carcinoma MCF-7, and human ovarian carcinoma SKOV-3 cells during cisplatin resistance development. It was found that drug resistance formation was accompanied by a significant increase in the expression of PRDX1, PRDX2, PRDX3, PRDX6 genes in all cancer cell strains, which confirms the important contribution of redox-dependent mechanisms into the development of cisplatin resistance of cancer cells.


Assuntos
Neoplasias da Mama/genética , Carcinoma/genética , Leucemia Eritroblástica Aguda/genética , Neoplasias Ovarianas/genética , Peroxirredoxina III/genética , Peroxirredoxina VI/genética , Peroxirredoxinas/genética , Antineoplásicos/farmacologia , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/enzimologia , Carcinoma/tratamento farmacológico , Carcinoma/enzimologia , Linhagem Celular Tumoral , Cisplatino/farmacologia , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Resistencia a Medicamentos Antineoplásicos/genética , Feminino , Expressão Gênica/efeitos dos fármacos , Humanos , Leucemia Eritroblástica Aguda/tratamento farmacológico , Leucemia Eritroblástica Aguda/enzimologia , Neoplasias Ovarianas/tratamento farmacológico , Neoplasias Ovarianas/enzimologia , Estresse Oxidativo , Peroxirredoxina III/metabolismo , Peroxirredoxina VI/metabolismo , Peroxirredoxinas/metabolismo
3.
Arkh Patol ; 72(4): 24-7, 2010.
Artigo em Russo | MEDLINE | ID: mdl-21086633

RESUMO

A female patient with recurrent bladder cancer underwent complex examination. The primary tumor removed in 2004 showed human papillomavirus (HPV) 16 DNA, mRNA corresponding to HPV16 oncogene E7, as well as HPV16 protein E7. The patient is a smoker who has been working at a chemical factory for over 20 years. During tumor recurrence in 2009, there was no DNA of high-risk HPV types in the cancer cells. HPV16 E7protein and cellular p 16(INK4alpha), an indicator of HPV-induced carcinogenesis, were not found. Colposcopy revealed no precancerous changes in the epithelium of the cervix uteri. The cervical epitheliocytes contained no high-risk HPV DNA, E7 and p16(INK4alpha) proteins. It seems expedient to continue in vitro studies of the possible role of HPV in urothelial carcinogenesis on an experimental model.


Assuntos
Papillomavirus Humano 16 , Recidiva Local de Neoplasia/virologia , Infecções por Papillomavirus/virologia , Infecções Tumorais por Vírus/virologia , Neoplasias da Bexiga Urinária/virologia , Inibidor p16 de Quinase Dependente de Ciclina/metabolismo , Feminino , Humanos , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/metabolismo , Recidiva Local de Neoplasia/patologia , Recidiva Local de Neoplasia/cirurgia , Proteínas E7 de Papillomavirus/metabolismo , Infecções por Papillomavirus/metabolismo , Infecções por Papillomavirus/patologia , Infecções por Papillomavirus/cirurgia , RNA Mensageiro/metabolismo , Infecções Tumorais por Vírus/metabolismo , Infecções Tumorais por Vírus/patologia , Infecções Tumorais por Vírus/cirurgia , Neoplasias da Bexiga Urinária/metabolismo , Neoplasias da Bexiga Urinária/patologia , Neoplasias da Bexiga Urinária/cirurgia
4.
Bull Exp Biol Med ; 149(2): 242-5, 2010 Aug.
Artigo em Inglês, Russo | MEDLINE | ID: mdl-21113501

RESUMO

Hyperexpression of p16(INK4a) protein is an early marker of cervical cancer. Hyperexpression of INK4a gene encoding this protein at the level of mRNA and p16(INK4a) was detected in tumor cells of some patients with bladder cancer associated with human papilloma virus-16. However, in contrast to cervical cancer, this phenomenon in urothelial carcinomas does not correlate with expression of human papilloma virus-16 oncogenes E6 and E7.


Assuntos
Biomarcadores Tumorais/metabolismo , Inibidor p16 de Quinase Dependente de Ciclina/metabolismo , Papillomavirus Humano 16 , Neoplasias da Bexiga Urinária/diagnóstico , Neoplasias da Bexiga Urinária/metabolismo , Neoplasias da Bexiga Urinária/virologia , Primers do DNA/genética , Humanos , Imuno-Histoquímica , Proteínas Oncogênicas Virais/metabolismo , Proteínas E7 de Papillomavirus/metabolismo , Proteínas Repressoras/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa
5.
Mol Biol (Mosk) ; 42(5): 765-71, 2008.
Artigo em Russo | MEDLINE | ID: mdl-18988526

RESUMO

Integrity of genome is a prerequisite for cell viability. Therefore, targeted damage of DNA structure is considered the key approach to the induction of cell death. Among the plethora of death execution programs the mitochondrial events are of the utmost importance. However, the epigemetic activation of defense mechanisms in response to DNA damage limit cell death. This review analyses the outcome of the genotoxic stress (i.e., cell death versus survival) as a balance of pro- and anti-apoptotic signaling. Practically speaking, the combinations of DNA damaging agents with the inhibitors of anti-apoptosis would increase the efficacy of anticancer therapy.


Assuntos
Apoptose/fisiologia , Dano ao DNA/fisiologia , Reparo do DNA/fisiologia , Mitocôndrias/fisiologia , Apoptose/efeitos dos fármacos , Apoptose/efeitos da radiação , Ciclo Celular/efeitos dos fármacos , Ciclo Celular/fisiologia , Ciclo Celular/efeitos da radiação , Dano ao DNA/efeitos dos fármacos , Dano ao DNA/efeitos da radiação , Reparo do DNA/efeitos dos fármacos , Reparo do DNA/efeitos da radiação , DNA Mitocondrial/metabolismo , Epigênese Genética/fisiologia , Humanos , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/efeitos da radiação , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/fisiologia , Transdução de Sinais/efeitos da radiação , Proteína Supressora de Tumor p53/metabolismo
6.
Biofizika ; 52(5): 869-75, 2007.
Artigo em Russo | MEDLINE | ID: mdl-17969921

RESUMO

It was found that dinitrosyl iron complexes (DNIC) with thiol-containing ligands (cysteine or glutathione) of concentrations up to 1 mM produce no cytotoxic effect on cultured cells from human milk gland carcinoma (MCF-7). The cytotoxic action on MCF-7 cells was produced by S-nitrosocysteine: at a concentration of 1 mM, it induced the death of 50% cells. A more stable S-nitrosothiol, S-nitrosoglutathione, did not produce any cytotoxic effect at the same concentration. It is assumed that the negative action of nitrosocysteine is due to its rapid degradation, which results in the accumulation of large amounts of free NO molecules followed by their oxidation by superoxide ions to peroxynitrite, an efficient inhibitor of metabolic processes. These processes seem to be not characteristic of the more stable S-nitrosoglutathione. The cytotoxic effect of nitrosocysteine was completlly abrogated by the addition of 0.2 mM ferrous citrate complex to the medium. When S-nitrosoglutathione NO (0.5 mM) or S-nitrosoglutathione (0.5 mM) + Fe(2+)-citrate (0.2 mM) were added to the medium, protein-bound dinitrosyl iron complexes formed with the involvement of endogenous or exogenous iron were detected in cells. The amount of the complexes in the presence of exogenous iron increased four times, reaching the value of 1.6 nmole/5 x 10(6) cells. Therefore, it was proposed that the blockade of the cytotoxic action of S-nitrosoglutathione by iron complexes is due to Cys-NO transformation of S-nitrosocysteine into dinitrosyl iron complexes. The high stability of these complexes ensures only a gradual accumulation of nitric oxide in cells.


Assuntos
Ferro/farmacologia , Óxido Nítrico/metabolismo , Óxidos de Nitrogênio/farmacologia , Ácido Peroxinitroso/metabolismo , S-Nitrosoglutationa/farmacologia , Superóxidos/metabolismo , Animais , Morte Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Cisteína/metabolismo , Cisteína/farmacologia , Relação Dose-Resposta a Droga , Espectroscopia de Ressonância de Spin Eletrônica , Humanos , Ferro/metabolismo , Óxidos de Nitrogênio/metabolismo , Oxirredução/efeitos dos fármacos , S-Nitrosoglutationa/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA